BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37254089)

  • 1. MRI-based radiomics model and nomogram for predicting the outcome of locoregional treatment in patients with hepatocellular carcinoma.
    Wang Y; Liu Z; Xu H; Yang D; Jiang J; Asayo H; Yang Z
    BMC Med Imaging; 2023 May; 23(1):67. PubMed ID: 37254089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.
    Kong C; Zhao Z; Chen W; Lv X; Shu G; Ye M; Song J; Ying X; Weng Q; Weng W; Fang S; Chen M; Tu J; Ji J
    Eur Radiol; 2021 Oct; 31(10):7500-7511. PubMed ID: 33860832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction.
    Zhang Z; Jiang H; Chen J; Wei Y; Cao L; Ye Z; Li X; Ma L; Song B
    Cancer Imaging; 2019 May; 19(1):22. PubMed ID: 31088553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting hepatocellular carcinoma early recurrence after ablation based on magnetic resonance imaging radiomics nomogram.
    Yang X; Yuan C; Zhang Y; Li K; Wang Z
    Medicine (Baltimore); 2022 Dec; 101(52):e32584. PubMed ID: 36596081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of therapeutic response of unresectable hepatocellular carcinoma to hepatic arterial infusion chemotherapy based on pretherapeutic MRI radiomics and Albumin-Bilirubin score.
    Zhao Y; Huang F; Liu S; Jian L; Xia X; Lin H; Liu J
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5181-5192. PubMed ID: 36369395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A radiomics nomogram based on contrast-enhanced MRI for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma.
    Zhu Y; Weng S; Li Y; Yan C; Ye R; Wen L; Zhou L; Gao L
    Abdom Radiol (NY); 2021 Jul; 46(7):3139-3148. PubMed ID: 33641018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation a radiomics nomogram for predicting thymidylate synthase status in hepatocellular carcinoma based on Gd-DTPA contrast enhanced MRI.
    Ding Z; Wu Y; Fang G; Lin Z; Lin K; Fu J; Huang Q; Tang Y; You W; Liu J; Zeng Y
    BMC Cancer; 2023 Oct; 23(1):991. PubMed ID: 37848807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma.
    Zhou Y; Zhou G; Zhang J; Xu C; Zhu F; Xu P
    Eur Radiol; 2022 Jul; 32(7):5004-5015. PubMed ID: 35128572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure.
    Zhu WS; Shi SY; Yang ZH; Song C; Shen J
    World J Gastroenterol; 2020 Mar; 26(11):1208-1220. PubMed ID: 32231424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CT-based radiomics nomogram for differentiation of focal nodular hyperplasia from hepatocellular carcinoma in the non-cirrhotic liver.
    Nie P; Yang G; Guo J; Chen J; Li X; Ji Q; Wu J; Cui J; Xu W
    Cancer Imaging; 2020 Feb; 20(1):20. PubMed ID: 32093786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
    Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
    Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral and peritumoral radiomics based on contrast-enhanced MRI for preoperatively predicting treatment response of transarterial chemoembolization in hepatocellular carcinoma.
    Zhao Y; Zhang J; Wang N; Xu Q; Liu Y; Liu J; Zhang Q; Zhang X; Chen A; Chen L; Sheng L; Song Q; Wang F; Guo Y; Liu A
    BMC Cancer; 2023 Oct; 23(1):1026. PubMed ID: 37875815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative Evaluation of Gd-EOB-DTPA-Enhanced MRI Radiomics-Based Nomogram in Small Solitary Hepatocellular Carcinoma (≤3 cm) With Microvascular Invasion: A Two-Center Study.
    Tian Y; Hua H; Peng Q; Zhang Z; Wang X; Han J; Ma W; Chen J
    J Magn Reson Imaging; 2022 Nov; 56(5):1459-1472. PubMed ID: 35298849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI-Based Radiomics: Nomograms predicting the short-term response after transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma patients with diameter less than 5 cm.
    Kuang Y; Li R; Jia P; Ye W; Zhou R; Zhu R; Wang J; Lin S; Pang P; Ji W
    Abdom Radiol (NY); 2021 Aug; 46(8):3772-3789. PubMed ID: 33713159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma.
    Chen YD; Zhang L; Zhou ZP; Lin B; Jiang ZJ; Tang C; Dang YW; Xia YW; Song B; Long LL
    World J Gastroenterol; 2022 Aug; 28(31):4399-4416. PubMed ID: 36159011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.
    Niu XK; He XF
    World J Gastroenterol; 2021 Jan; 27(2):189-207. PubMed ID: 33510559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A radiomics nomogram for predicting transcatheter arterial chemoembolization refractoriness of hepatocellular carcinoma without extrahepatic metastasis or macrovascular invasion.
    Sheen H; Kim JS; Lee JK; Choi SY; Baek SY; Kim JY
    Abdom Radiol (NY); 2021 Jun; 46(6):2839-2849. PubMed ID: 33388805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Hu S; Kang Y; Xie Y; Yang T; Yang Y; Jiao J; Zou Q; Zhang H; Zhang Y
    Abdom Radiol (NY); 2023 Feb; 48(2):532-542. PubMed ID: 36370179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiomics nomogram based on multi-parametric magnetic resonance imaging for predicting early recurrence in small hepatocellular carcinoma after radiofrequency ablation.
    Zhang X; Wang C; Zheng D; Liao Y; Wang X; Huang Z; Zhong Q
    Front Oncol; 2022; 12():1013770. PubMed ID: 36439458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.